Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

ITNS
ITonis, Inc.

Common Stock

0.0004

0.00

0.00%

0.0003 / 0.0004 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/18/2025
Delayed (15 Min) Trade Data: 12:00am 07/17/2025
OTC Disclosure & News Service
Itonis Pharmaceutical's EMESYL(TM) Nausea Relief Convenience Store Test Market Begins in Lodi, California

Itonis Pharmaceutical's EMESYL(TM) Nausea Relief Convenience Store Test Market Begins in Lodi, California

LAGUNA HILLS, CA--(Marketwired - Feb 11, 2015) - Itonis, Inc. (OTC PINK: ITNS)

Itonis announced that the distributor of EMESYL™ Nausea Relief (Hensley Brothers Distribution, LLC) has commenced its convenience store test marketing of EMESYL™ Nausea Relief in Lodi, California. The first series of Lodi stores stocked are ARCO Mini-Marts located on N. Flag City Blvd, W. Lockeford Street, and E. Victor Road. 

"The test marketing is important for several reasons. ARCO is nationally represented and presents an opportunity for national penetration and visibility and the compact size of the outlets allows for efficient market analysis," said Steven Hensley, Vice-President of Hensley Brothers Distribution. "Furthermore, retail outlets such as ARCO are the 'to go' place when road travelers look for immediate relief from motion sickness."

"We are pleased at the progress our distributor has made towards getting EMESYL™ Nausea Relief on the shelves across the nation," said Mark Cheung, CEO of Itonis. 

With Hensley Brothers, the Company is marketing EMESYL™ for sale, leading up to the August 2015 National Association of Chain Drug Stores (NACDS) Total Store Expo that will be held in Denver, Colorado.

About EMESYL
www.itonisholdings.com/emesyl and http://www.emesyl.com/emesyl.

About Itonis Pharmaceuticals

Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on the distribution of innovative products to the medical and pharmaceutical industry. Please the Company at www.itonisholdings.com.

Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.

Contact:
Itonis, Inc.
Email Contact

The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.
Limited Information Icon
Pink Limited Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.